WO2007041336A1 - System and method for pre-processing waveforms - Google Patents

System and method for pre-processing waveforms Download PDF

Info

Publication number
WO2007041336A1
WO2007041336A1 PCT/US2006/038127 US2006038127W WO2007041336A1 WO 2007041336 A1 WO2007041336 A1 WO 2007041336A1 US 2006038127 W US2006038127 W US 2006038127W WO 2007041336 A1 WO2007041336 A1 WO 2007041336A1
Authority
WO
WIPO (PCT)
Prior art keywords
physiological
decompositions
monitoring system
morphological operations
resolution
Prior art date
Application number
PCT/US2006/038127
Other languages
French (fr)
Inventor
Li Li
Scott Amundson
Michael Patrick O'neil
Original Assignee
Nellcor Puritan Bennett Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nellcor Puritan Bennett Llc filed Critical Nellcor Puritan Bennett Llc
Publication of WO2007041336A1 publication Critical patent/WO2007041336A1/en

Links

Classifications

    • GPHYSICS
    • G06COMPUTING; CALCULATING OR COUNTING
    • G06FELECTRIC DIGITAL DATA PROCESSING
    • G06F18/00Pattern recognition
    • GPHYSICS
    • G06COMPUTING; CALCULATING OR COUNTING
    • G06FELECTRIC DIGITAL DATA PROCESSING
    • G06F2218/00Aspects of pattern recognition specially adapted for signal processing
    • G06F2218/02Preprocessing

Definitions

  • the present invention relates generally to the processing of waveform data and, more particularly, to the processing of waveforms associated with medical monitoring.
  • Pulse oximetry may be used to measure various blood flow characteristics, such as the blood-oxygen saturation of hemoglobin in arterial blood, the volume of individual blood pulsations supplying the tissue, and/or the rate of blood pulsations corresponding to each heartbeat of a patient.
  • the quality of these measurements may be adversely affected by a number of factors such as patient motion, subdermal physiological structures, poor sensor operation or fit, poor signal reception and transmission, and so forth. Such factors may result in a pulse oximetry signal which contains artifacts or noise or is otherwise of low or reduced quality. When processed, such a low or reduced quality signal may result in physiological measurements being reported which may not be as accurate or reliable as desired.
  • a method for processing a physiological signal including the acts of: performing one or more multi-resolution decompositions on a physiological signal to generate high-passed components and low-passed components; and performing one or more morphological operations on at least one of the high-passed components or the low-passed components generated by the one or more of the respective multi-resolution decompositions.
  • one or more machine-readable media including: a routine configured to perform one or more multi-resolution decompositions on a physiological signal to generate high-passed components and low-passed components; and a routine configured to perform one or more morphological operations on at least one of the high- passed components or the low-passed components generated by the one or more of the respective multi-resolution decompositions.
  • a physiological monitoring system including: a sensor configured to generate a physiological signal; and a monitor configured to display one or more physiological parameters derived from a modified version of the physiological signal, wherein the modified version is generated by performing one or more multi-resolution decompositions on the physiological signal to generate high-passed components and low- passed components, performing one or more morphological operations on at least one of the high-passed components or the low-passed components generated by the one or more of the respective multi-resolution decompositions, and reconstructing the modified version from one or more modified wavelet coefficients generated by the one or more morphological operations.
  • a physiological monitoring system including: a sensor configured to generate a physiological signal; and a monitor configured to perform one or more multi- resolution decompositions on the physiological signal to generate high-passed components and low-passed components, and configured to perform one or more morphological operations on at least one of the high-passed components or the low-passed components generated by the one or more of the respective multi-resolution decompositions.
  • Fig. 1 illustrates a patient monitoring system coupled to a multi-parameter patient monitor and a bi-stable sensor, in accordance with aspects of the present technique
  • Fig. 2 is a flowchart of exemplary actions performed in accordance with aspects of the present technique
  • Fig. 3 C depicts the wavelet vector of Fig. 3B modified by suitable morphological operations, in accordance with aspects of the present technique.
  • Fig. 3D depicts an output waveform reconstructed from the modified wavelet coefficients of Fig. 3 C, in accordance with aspects of the present technique.
  • an output signal from a pulse oximeter (or other medical monitor) in which the artifacts and/or noise have been removed or reduced.
  • Such a "clean" output signal may then be processed to generate accurate and reliable physiological measurements of interest, such as measurements of blood oxygen level (SpO 2 ), pulse rate, and so forth.
  • an output signal from a medical monitor is pre-processed to remove noise and/or artifacts. The pre-processed signal may then be used to accurately derive the desired physiological measurements of interest.
  • the exemplary system includes a physiological sensor 10 that may be attached to a patient.
  • the sensor 10 generates an output signal based on a monitored physiological characteristic and transmits the, output signal to a patient monitor 12, in accordance with the present technique.
  • the sensor 10 is connected to the patient monitor 12 via a cable 14 suitable for transmission of the output signal as well as any other electrical and/or optical signals or impulses communicated between the sensor 10 and monitor 12.
  • the senor 10 and/or the cable 14 may include or incorporate one or more integrated circuit devices or electrical devices, such as a memory, processor chip, or resistor, that may facilitate or enhance communication between the sensor 10 and the patient monitor 12.
  • the cable 14 may be an adaptor cable, with or without an integrated circuit or electrical device, for facilitating communication between the sensor 10 and various types of monitors, including older or newer versions of the patient monitor 12 or other physiological monitors, hi other embodiments, the sensor 10 and the patient monitor 12 may communicate via wireless means, such as using radio, infrared, or optical signals, hi such embodiments, a transmission device (not shown) may be connected to the sensor 10 to facilitate wireless transmission between the sensor 10 and the patient monitor 12.
  • the patient monitor 12 maybe a suitable pulse oximeter, such as those available from Nellcor Puritan Bennett Inc. In other embodiments, the patient monitor 12 may be a monitor suitable for measuring other physiological characteristics
  • the monitor 12 may be a multipurpose monitor suitable for performing pulse oximetry and/or other physiological and/or biochemical monitoring processes using data acquired via the sensor 10.
  • the patient monitor 12 may be coupled to a multi-parameter patient monitor 16 via a cable 18 connected to a sensor input port and/or via a cable 20 connected to a digital communication port.
  • the sensor 10 is an exemplary spectrophotometry sensor (such as a pulse oximetry sensor or probe) that includes an emitter 22 and a detector 24 which may be of any suitable type.
  • the emitter 22 may be one or more light emitting diodes adapted to transmit one or more wavelengths of light, such as in the red to infrared range
  • the detector 24 may be a photodetector, such as a silicon photodiode package, selected to receive light in the range emitted from the emitter 22.
  • the senor 10 is coupled to a cable 14 through which electrical and/or optical signals may be transmitted to and/or from the emitter 22 and detector 24.
  • the sensor 10 maybe configured for use with the emitter and detector on the same side of the sensor site (i.e., as a "reflectance type” sensor) or on opposite sides of the sensor site (i.e., as a "transmission type” sensor).
  • the emitter 22 shines one or more wavelengths of light through the patient's fingertip, or other tissue, and the light received by the detector 24 is processed to determine one or more physiological characteristics of the patient.
  • the oxygen saturation of the patient's arterial blood may be determined using two or more wavelengths of light emitted by the emitter 22, most commonly red and near infrared wavelengths. After passage through the patient's tissue, a portion of the light emitted at these wavelengths is detected by the detector 24.
  • the detector generates one or more signals, such an electrical or optical signals, in response to the amount of each wavelength that is detected at a given time.
  • the generated signals may be digital or, where acquired as analog signals, may be digitized in implementations where digital processing and manipulation of the signals is employed. Such digitalization may be performed at the monitor 12 or prior to reaching the monitor 12.
  • the signals may be transmitted via the cable 14 to the monitor 12, where the oxygen saturation or other physiological characteristic is calculated based on the signals.
  • the signals output received by the monitor 12 for processing may be noisy or contain artifacts due to a variety of factors, such as light modulation by subdermal anatomic structures, patient motion during data acquisition, poor sensor operation or fit, poor signal reception and transmission, and so forth.
  • the physiological characteristics such as blood oxygen levels
  • the output signals are pre-processed prior to deriving the one or more physiological characteristics.
  • An example of such an embodiment is set forth in Fig.
  • an oximetry data signal 40 i.e., a plethysmographic waveform, such as may be generated by a sensor 10 suitable for pulse oximetry, is pre-processed to remove artifacts and noise prior to extraction of the desired physiological data.
  • a oximetry data signal 40 i.e., a plethysmographic waveform, such as may be generated by a sensor 10 suitable for pulse oximetry
  • the pre-processing of the data signal 40 may merely be a prelude to further processing for physiological parameters, one of ordinary skill in the art will appreciate that the pre-processed signal may itself be of interest. For example, the pre-processed signal may itself be monitored or used to generate alarms where appropriate.
  • the oximetry data signal 40 may, optionally, be filtered (block 42) to smooth out or remove aspects of the signal 40 which are not believed to be representative of the desired physiological data, thereby generating a filtered signal 44.
  • the oximetry signal 40 is median filtered at block 40 to remove outlier noise that may be the result of electronic noise or other non-physiological factors.
  • Such filtered signals 44 may then be further processed in accordance with the present technique.
  • the oximetry signals 40 may then be processed using a multi-resolution decomposition technique to decompose the signals into time-frequency or time-scale components, such as by discrete wavelet transformation (block 46) via a filter bank or other multiple or iterative decomposition implementation.
  • a multi-resolution decomposition technique to decompose the signals into time-frequency or time-scale components, such as by discrete wavelet transformation (block 46) via a filter bank or other multiple or iterative decomposition implementation.
  • Such decompositions provide time and frequency information about the decomposed signal which may be subsequently processed.
  • wavelet transformation is discussed herein, those of ordinary skill in the art will appreciate that other transformation techniques capable of providing the desired time and frequency information may also be employed and are within the scope of the present technique.
  • each wavelet decomposition yields a low frequency or low-passed signal component 48 in the form of wavelet coefficients, which corresponds to an approximation of the signal undergoing decomposition, and a high frequency or high-passed signal component 50, which corresponds to detail components of the signal undergoing decomposition, hi one implementation, each iteration, i.e., resolution level, of the decomposition decomposes the previous approximation, i.e., low-passed component 48, yielding an approximation and detail component representative of the previous approximation, hi other words, the low-passed component 48 at the previous resolution level is decomposed to yield the high-passed 50 and low-passed components 48 of the current resolution level.
  • each previous resolution level may be reproduced by reintegrating the low-passed 48 and high-passed components 50 (i.e., the approximation and details) of the current resolution level.
  • the initial signal may be reproduced by reintegrating the current resolution level of approximation and details along with previous resolution levels of detail.
  • Some or all of the high-passed 50 and/or low-passed 48 filtered components generated at some or all of the decomposition resolution levels may be processed using one or more morphological operations (block 56) to generate modified wavelet coefficients 58 which may be subsequently reconstructed to generate an output waveform with reduced noise and/or artifacts.
  • the morphological operations smooth out the low-passed components 48 (i.e., approximations) and/or the high-passed components 50 (i.e., the details).
  • morphological operations performed on some or all of the filtered components at selected resolution levels may remove noise, facilitate the detection of transient edges, and/or facilitate the identification of a cutoff scale from which the processed signal will be reconstructed. In this manner, analysis at the subsequent resolution level may be facilitated.
  • the oximetry signal 40 undergoes a three-stage wavelet decomposition to generate the respective high-passed components 50 and low-passed components 48.
  • morphological operations are applied to all three resulting scales generated by the first two rounds of wavelet decomposition
  • hi another implementation only the two high-pass sub-bands are processed with morphological filters after two rounds of wavelet decomposition
  • the morphological operations performed may be selected based on the frequency of the respective components, i.e., different morphological filtering schemes may be applied to different frequency ranges or scales of the wavelet transformed signal.
  • Examples of morphological operations that may be performed at block 56 include dilation and erosion operations or other forms of direction, structural, and/or shape-based filtering operations.
  • a shape or pattern presumed to be present in the data and the filter operation is performed accordingly to emphasize or enhance portions of the data where more points are expected (i.e., a dilation) and/or to remove portions of the data where fewer points are expected (i.e., an erosion).
  • different effects may be accomplished in the data by varying the number of erosion and/or dilation operations performed or by varying the order in which an erosion and a dilation operation are performed.
  • multiple periods or pulses of waveform data may be analyzed prior to determine an average or underlying shape of the waveform, i.e., the expected structural elements.
  • This average or underlying shape may then be used as a template or expected shape for the subsequent morphological operations, hi this way, erosions, dilations, or other morphological operations may be performed on the data to compensate for differences between the measured data and the expected structural elements within the data, thereby compensating for artifacts which may cause deviations from the expected structural elements.
  • the structural elements may differ at different resolutions, such as having different amplitudes, slope changes and so forth.
  • the artifacts being compensated may be multi-dimensional with their own wavelet components at some or all of the resolution levels. Therefore, identification of structural elements and compensation for artifacts via morphological operations may vary depending on the respective resolution level.
  • the decomposition and morphological filtering operations may continue until a set number of iterations have been performed or until some other threshold has been reached, as determined at block 60.
  • the decomposition process is performed until the difference threshold between successive decomposed components, such as low-passed components 48, is below a desired difference threshold.
  • a threshold may be empirically determined from a database of coefficients and differences or by other means. While the present example depicts only the low-passed components
  • modified wavelet coefficients 58 which, once pre-processing is determined to be complete at block 60, may be reconstructed (block 62) to generate the desired clean waveform 64.
  • This clean waveform 64 may be processed to determine one or more physiological characteristics of interest, such as respiratory information, blood oxygen saturation, pulse rate, and so forth.
  • Figs. 3A-3D example waveforms representative of the technique set forth in Fig. 2 are provided for the purpose of illustration.
  • Fig. 3 A depicts an oximetry signal 40, as provide in Fig. 2.
  • the signal 40 of Fig. 3 A contains noise and artifacts which are undesirable and which may lead to inaccuracies in subsequent data analyses.
  • Fig. 3B depicts a three-stage wavelet decomposition 70 of the original signal
  • the three-stage decomposition 70 includes a first high-passed component 72.
  • the first low-passed component was further decomposed to yield a second high-passed component 74 and a second low-passed component that was in turn subsequently decomposed to generate a third low-passed component 76 and a third high-passed component 78.
  • the third low-passed component 76 represents the approximation data for the original signal while the first, second, and third high-passed components 72, 74, 78 represent different levels of detail.
  • Fig. 3 C depicts the modified wavelet vector 80 generated by performing morphological operations (such as erosion and dilation operations) on all the components of the three-stage decomposition 70.
  • the modified wavelet vector 80 provides the wavelet coefficients 58 that may be reconstructed, such as by an inverse wavelet transform, to generate the output waveform 64 of Fig. 2.
  • the inverse wavelet transform preserves the original physiological data while allowing artifact compensation, as opposed to techniques using synthesized waveforms (such as triangular synthetic waveforms) where physiological information may be lost.
  • the output waveform 64 is smoothed out relative to the original signal 40 with much of the noise and artifacts of the original signal removed.
  • the output waveform 64 may be provided to subsequent processes for the determination of physiological characteristics of interest, such as blood oxygen saturation, pulse rate and so forth.
  • the techniques and processes discussed herein may be implemented as one or more automated routines or processes which maybe stored and/or executed on suitable components of the monitor 12 or multi-parameter monitor 16.
  • suitable components of the monitor 12 or multi-parameter monitor 16 may be provided on the sensor 10 and/or cable 14, 18, or 20, some or all aspects of the present technique may be stored and/or executed by these respective components.
  • different aspects of the present technique may be stored and/or executed on different portions of a suitable physiological monitoring system where such divisions are desirable.

Abstract

A technique is provided for processing a physiological signal. The technique includes performing one or more multi-resolution decompositions on a physiological signal and one or more morphological operations on some or all of the respective decomposition components. In one embodiment, the technique is implemented as iteratively wavelet transformations where morphological operations, such as erosions and dilations, are applied to modify some or all of the respective wavelet coefficients. The modified wavelet coefficients may then be reconstructed to generate a clean version of the physiological signal from which some or all of the noise and/or artifacts have been removed.

Description

SYSTEM AND METHOD FOR PRE-PROCESSING WAVEFORMS
BACKGROUND OF THE INVENTION
1. Field Of The Invention
The present invention relates generally to the processing of waveform data and, more particularly, to the processing of waveforms associated with medical monitoring.
2. Description Of The Related Art This section is intended to introduce the reader to various aspects of art that may be related to various aspects of the present invention, which are described and/or claimed below. This discussion is believed to be helpful in providing the reader with background information to facilitate a better understanding of the various aspects of the present invention. Accordingly, it should be understood that these statements are to be read in this light, and not as admissions of prior art.
In the field of medicine, doctors often desire to monitor certain physiological characteristics of their patients. Accordingly, a wide variety of devices have been developed for monitoring physiological characteristics. Such devices provide doctors and other healthcare personnel with the information they need to provide the best possible healthcare for their patients. As a result, such monitoring devices have become an indispensable part of modern medicine.
One technique for monitoring certain physiological characteristics of a patient is commonly referred to as pulse oximetry, and the devices built based upon pulse oximetry techniques are commonly referred to as pulse oximeters. Pulse oximetry may be used to measure various blood flow characteristics, such as the blood-oxygen saturation of hemoglobin in arterial blood, the volume of individual blood pulsations supplying the tissue, and/or the rate of blood pulsations corresponding to each heartbeat of a patient.
The quality of these measurements, however, maybe adversely affected by a number of factors such as patient motion, subdermal physiological structures, poor sensor operation or fit, poor signal reception and transmission, and so forth. Such factors may result in a pulse oximetry signal which contains artifacts or noise or is otherwise of low or reduced quality. When processed, such a low or reduced quality signal may result in physiological measurements being reported which may not be as accurate or reliable as desired.
SUMMARY
Certain aspects commensurate in scope with the originally claimed invention are set forth below. It should be understood that these aspects are presented merely to provide the reader with a brief summary of certain forms the invention might take and that these aspects are not intended to limit the scope of the invention. Indeed, the invention may encompass a variety of aspects that may not be set forth below.
There is provided a method for processing a physiological signal, the method including the acts of: performing one or more multi-resolution decompositions on a physiological signal to generate high-passed components and low-passed components; and performing one or more morphological operations on at least one of the high-passed components or the low-passed components generated by the one or more of the respective multi-resolution decompositions.
There is provided one or more machine-readable media, including: a routine configured to perform one or more multi-resolution decompositions on a physiological signal to generate high-passed components and low-passed components; and a routine configured to perform one or more morphological operations on at least one of the high- passed components or the low-passed components generated by the one or more of the respective multi-resolution decompositions.
There is provided a physiological monitoring system, including: a sensor configured to generate a physiological signal; and a monitor configured to display one or more physiological parameters derived from a modified version of the physiological signal, wherein the modified version is generated by performing one or more multi-resolution decompositions on the physiological signal to generate high-passed components and low- passed components, performing one or more morphological operations on at least one of the high-passed components or the low-passed components generated by the one or more of the respective multi-resolution decompositions, and reconstructing the modified version from one or more modified wavelet coefficients generated by the one or more morphological operations.
There is provided a physiological monitoring system, including: a sensor configured to generate a physiological signal; and a monitor configured to perform one or more multi- resolution decompositions on the physiological signal to generate high-passed components and low-passed components, and configured to perform one or more morphological operations on at least one of the high-passed components or the low-passed components generated by the one or more of the respective multi-resolution decompositions.
BRIEF DESCRIPTION QF THE DRAWINGS
Advantages of the invention may become apparent upon reading the following detailed description and upon reference to the drawings in which:
Fig. 1 illustrates a patient monitoring system coupled to a multi-parameter patient monitor and a bi-stable sensor, in accordance with aspects of the present technique; Fig. 2 is a flowchart of exemplary actions performed in accordance with aspects of the present technique;
Fig. 3A depicts a waveform representing a pulse oximetry signal to be processed in accordance with aspects of the present technique;
Fig. 3B depicts wavelet transformation of the waveform of Fig. 3 A, in accordance with aspects of the present technique;
Fig. 3 C depicts the wavelet vector of Fig. 3B modified by suitable morphological operations, in accordance with aspects of the present technique; and
Fig. 3D depicts an output waveform reconstructed from the modified wavelet coefficients of Fig. 3 C, in accordance with aspects of the present technique.
DETAILED DESCRIPTION OF SPECIFIC EMBODIMENTS
One or more specific embodiments of the present invention will be described below. In an effort to provide a concise description of these embodiments, not all features of an actual implementation are described in the specification. It should be appreciated that in the development of any such actual implementation, as in any engineering or design project, numerous implementation-specific decisions must be made to achieve the developers' specific goals, such as compliance with system-related and business-related constraints, which may vary from one implementation to another. Moreover, it should be appreciated that such a development effort might be complex and time consuming, but would nevertheless be a routine undertaking of design, fabrication, and manufacture for those of ordinary skill having the benefit of this disclosure.
It is desirable to provide an output signal from a pulse oximeter (or other medical monitor) in which the artifacts and/or noise have been removed or reduced. Such a "clean" output signal may then be processed to generate accurate and reliable physiological measurements of interest, such as measurements of blood oxygen level (SpO2), pulse rate, and so forth. In accordance with some aspects of the present technique, an output signal from a medical monitor is pre-processed to remove noise and/or artifacts. The pre-processed signal may then be used to accurately derive the desired physiological measurements of interest.
Turning now to Fig. 1, an exemplary medical monitoring system that may benefit from the present technique is depicted. The exemplary system includes a physiological sensor 10 that may be attached to a patient. The sensor 10 generates an output signal based on a monitored physiological characteristic and transmits the, output signal to a patient monitor 12, in accordance with the present technique. hi the depicted embodiment, the sensor 10 is connected to the patient monitor 12 via a cable 14 suitable for transmission of the output signal as well as any other electrical and/or optical signals or impulses communicated between the sensor 10 and monitor 12. As will be appreciated by those of ordinary skill in the art, the sensor 10 and/or the cable 14 may include or incorporate one or more integrated circuit devices or electrical devices, such as a memory, processor chip, or resistor, that may facilitate or enhance communication between the sensor 10 and the patient monitor 12. Likewise the cable 14 may be an adaptor cable, with or without an integrated circuit or electrical device, for facilitating communication between the sensor 10 and various types of monitors, including older or newer versions of the patient monitor 12 or other physiological monitors, hi other embodiments, the sensor 10 and the patient monitor 12 may communicate via wireless means, such as using radio, infrared, or optical signals, hi such embodiments, a transmission device (not shown) may be connected to the sensor 10 to facilitate wireless transmission between the sensor 10 and the patient monitor 12.
In one embodiment, the patient monitor 12 maybe a suitable pulse oximeter, such as those available from Nellcor Puritan Bennett Inc. In other embodiments, the patient monitor 12 may be a monitor suitable for measuring other physiological characteristics
(such as tissue water fraction, tissue or blood carbon dioxide levels, and so forth) using spectrophotometric or other techniques. Furthermore, the monitor 12 may be a multipurpose monitor suitable for performing pulse oximetry and/or other physiological and/or biochemical monitoring processes using data acquired via the sensor 10. Furthermore, to provide additional or enhanced functions to those performed by the monitor 12, the patient monitor 12 may be coupled to a multi-parameter patient monitor 16 via a cable 18 connected to a sensor input port and/or via a cable 20 connected to a digital communication port.
As noted above the data provided to the monitor 12 (or, alternatively, to the multi- parameter monitor 16) is generated at the sensor 10. In the example depicted in Fig. 1 , the sensor 10 is an exemplary spectrophotometry sensor (such as a pulse oximetry sensor or probe) that includes an emitter 22 and a detector 24 which may be of any suitable type. For example, the emitter 22 may be one or more light emitting diodes adapted to transmit one or more wavelengths of light, such as in the red to infrared range, and the detector 24 may be a photodetector, such as a silicon photodiode package, selected to receive light in the range emitted from the emitter 22. hi the depicted embodiment, the sensor 10 is coupled to a cable 14 through which electrical and/or optical signals may be transmitted to and/or from the emitter 22 and detector 24. The sensor 10 maybe configured for use with the emitter and detector on the same side of the sensor site (i.e., as a "reflectance type" sensor) or on opposite sides of the sensor site (i.e., as a "transmission type" sensor).
During operation, the emitter 22 shines one or more wavelengths of light through the patient's fingertip, or other tissue, and the light received by the detector 24 is processed to determine one or more physiological characteristics of the patient.
For example, for pulse oximetry applications the oxygen saturation of the patient's arterial blood (SaO2) may be determined using two or more wavelengths of light emitted by the emitter 22, most commonly red and near infrared wavelengths. After passage through the patient's tissue, a portion of the light emitted at these wavelengths is detected by the detector 24. The detector generates one or more signals, such an electrical or optical signals, in response to the amount of each wavelength that is detected at a given time. The generated signals may be digital or, where acquired as analog signals, may be digitized in implementations where digital processing and manipulation of the signals is employed. Such digitalization may be performed at the monitor 12 or prior to reaching the monitor 12. The signals, as noted above, may be transmitted via the cable 14 to the monitor 12, where the oxygen saturation or other physiological characteristic is calculated based on the signals. The signals output received by the monitor 12 for processing may be noisy or contain artifacts due to a variety of factors, such as light modulation by subdermal anatomic structures, patient motion during data acquisition, poor sensor operation or fit, poor signal reception and transmission, and so forth. In such instances, the physiological characteristics (such as blood oxygen levels) derived based on such noisy or artifact-containing data signals may in turn be inaccurate or unreliable. In an embodiment of the present technique, the output signals are pre-processed prior to deriving the one or more physiological characteristics. An example of such an embodiment is set forth in Fig. 2, depicting a pre-processing technique 38 for use in removing noise and artifacts from a physiological signal, hi this example, an oximetry data signal 40, i.e., a plethysmographic waveform, such as may be generated by a sensor 10 suitable for pulse oximetry, is pre-processed to remove artifacts and noise prior to extraction of the desired physiological data. While the pre-processing of the data signal 40 may merely be a prelude to further processing for physiological parameters, one of ordinary skill in the art will appreciate that the pre-processed signal may itself be of interest. For example, the pre-processed signal may itself be monitored or used to generate alarms where appropriate.
In accordance with an embodiment of the present technique, the oximetry data signal 40 may, optionally, be filtered (block 42) to smooth out or remove aspects of the signal 40 which are not believed to be representative of the desired physiological data, thereby generating a filtered signal 44. For example, in one implementation the oximetry signal 40 is median filtered at block 40 to remove outlier noise that may be the result of electronic noise or other non-physiological factors. Such filtered signals 44 may then be further processed in accordance with the present technique.
The oximetry signals 40 (or filtered signals 44) may then be processed using a multi-resolution decomposition technique to decompose the signals into time-frequency or time-scale components, such as by discrete wavelet transformation (block 46) via a filter bank or other multiple or iterative decomposition implementation. Such decompositions provide time and frequency information about the decomposed signal which may be subsequently processed. Though wavelet transformation is discussed herein, those of ordinary skill in the art will appreciate that other transformation techniques capable of providing the desired time and frequency information may also be employed and are within the scope of the present technique.
As will be appreciated by those of ordinary skill in the art, each wavelet decomposition yields a low frequency or low-passed signal component 48 in the form of wavelet coefficients, which corresponds to an approximation of the signal undergoing decomposition, and a high frequency or high-passed signal component 50, which corresponds to detail components of the signal undergoing decomposition, hi one implementation, each iteration, i.e., resolution level, of the decomposition decomposes the previous approximation, i.e., low-passed component 48, yielding an approximation and detail component representative of the previous approximation, hi other words, the low-passed component 48 at the previous resolution level is decomposed to yield the high-passed 50 and low-passed components 48 of the current resolution level. Because the low-passed components 48 are iteratively decomposed in such an implementation, each previous resolution level may be reproduced by reintegrating the low-passed 48 and high-passed components 50 (i.e., the approximation and details) of the current resolution level. Similarly, the initial signal may be reproduced by reintegrating the current resolution level of approximation and details along with previous resolution levels of detail.
Some or all of the high-passed 50 and/or low-passed 48 filtered components generated at some or all of the decomposition resolution levels may be processed using one or more morphological operations (block 56) to generate modified wavelet coefficients 58 which may be subsequently reconstructed to generate an output waveform with reduced noise and/or artifacts. In one embodiment, the morphological operations smooth out the low-passed components 48 (i.e., approximations) and/or the high-passed components 50 (i.e., the details). For example, morphological operations performed on some or all of the filtered components at selected resolution levels may remove noise, facilitate the detection of transient edges, and/or facilitate the identification of a cutoff scale from which the processed signal will be reconstructed. In this manner, analysis at the subsequent resolution level may be facilitated.
For example, in one embodiment, the oximetry signal 40 (or filtered signal 44) undergoes a three-stage wavelet decomposition to generate the respective high-passed components 50 and low-passed components 48. hi one implementation, morphological operations are applied to all three resulting scales generated by the first two rounds of wavelet decomposition, hi another implementation, only the two high-pass sub-bands are processed with morphological filters after two rounds of wavelet decomposition, hi general, the morphological operations performed may be selected based on the frequency of the respective components, i.e., different morphological filtering schemes may be applied to different frequency ranges or scales of the wavelet transformed signal.
Examples of morphological operations that may be performed at block 56 include dilation and erosion operations or other forms of direction, structural, and/or shape-based filtering operations. Typically in such operations, a shape or pattern presumed to be present in the data and the filter operation is performed accordingly to emphasize or enhance portions of the data where more points are expected (i.e., a dilation) and/or to remove portions of the data where fewer points are expected (i.e., an erosion). As will be appreciated by those of ordinary skill in the art, different effects may be accomplished in the data by varying the number of erosion and/or dilation operations performed or by varying the order in which an erosion and a dilation operation are performed.
For example, in one embodiment, multiple periods or pulses of waveform data (such as 10 samples) may be analyzed prior to determine an average or underlying shape of the waveform, i.e., the expected structural elements. This average or underlying shape may then be used as a template or expected shape for the subsequent morphological operations, hi this way, erosions, dilations, or other morphological operations may be performed on the data to compensate for differences between the measured data and the expected structural elements within the data, thereby compensating for artifacts which may cause deviations from the expected structural elements. As will be appreciated by those of ordinary skill in the art, the structural elements may differ at different resolutions, such as having different amplitudes, slope changes and so forth. Likewise, the artifacts being compensated may be multi-dimensional with their own wavelet components at some or all of the resolution levels. Therefore, identification of structural elements and compensation for artifacts via morphological operations may vary depending on the respective resolution level.
The decomposition and morphological filtering operations may continue until a set number of iterations have been performed or until some other threshold has been reached, as determined at block 60. For instance, in one embodiment, the decomposition process is performed until the difference threshold between successive decomposed components, such as low-passed components 48, is below a desired difference threshold. Such a threshold may be empirically determined from a database of coefficients and differences or by other means. While the present example depicts only the low-passed components
48 as being iteratively decomposed, those of ordinary skill in the art will appreciate that, in other implementations, some or all of the high-passed components 50 may also be iteratively decomposed.
The combination of morphological operations performed at block 56 on the respective high-passed 50 and/or low-passed components 48 result in modified wavelet coefficients 58 which, once pre-processing is determined to be complete at block 60, may be reconstructed (block 62) to generate the desired clean waveform 64. This clean waveform 64, in turn, may be processed to determine one or more physiological characteristics of interest, such as respiratory information, blood oxygen saturation, pulse rate, and so forth.
Referring now to Figs. 3A-3D, example waveforms representative of the technique set forth in Fig. 2 are provided for the purpose of illustration. Fig. 3 A depicts an oximetry signal 40, as provide in Fig. 2. The signal 40 of Fig. 3 A contains noise and artifacts which are undesirable and which may lead to inaccuracies in subsequent data analyses. Fig. 3B depicts a three-stage wavelet decomposition 70 of the original signal
40. The three-stage decomposition 70 includes a first high-passed component 72. The first low-passed component was further decomposed to yield a second high-passed component 74 and a second low-passed component that was in turn subsequently decomposed to generate a third low-passed component 76 and a third high-passed component 78. The third low-passed component 76 represents the approximation data for the original signal while the first, second, and third high-passed components 72, 74, 78 represent different levels of detail. Fig. 3 C depicts the modified wavelet vector 80 generated by performing morphological operations (such as erosion and dilation operations) on all the components of the three-stage decomposition 70. Morphological operations can also be applied to only the selected components at certain levels such as the first and second high passed components 72 and 74. The modified wavelet vector 80 provides the wavelet coefficients 58 that may be reconstructed, such as by an inverse wavelet transform, to generate the output waveform 64 of Fig. 2. In such an embodiment, the inverse wavelet transform preserves the original physiological data while allowing artifact compensation, as opposed to techniques using synthesized waveforms (such as triangular synthetic waveforms) where physiological information may be lost. The output waveform 64 is smoothed out relative to the original signal 40 with much of the noise and artifacts of the original signal removed. The output waveform 64 may be provided to subsequent processes for the determination of physiological characteristics of interest, such as blood oxygen saturation, pulse rate and so forth. As will be appreciated by those of ordinary skill in the art, the techniques and processes discussed herein may be implemented as one or more automated routines or processes which maybe stored and/or executed on suitable components of the monitor 12 or multi-parameter monitor 16. Alternatively, to the extent memory components and/or processing components may be provided on the sensor 10 and/or cable 14, 18, or 20, some or all aspects of the present technique may be stored and/or executed by these respective components. Furthermore, different aspects of the present technique may be stored and/or executed on different portions of a suitable physiological monitoring system where such divisions are desirable.
While the invention may be susceptible to various modifications and alternative forms, specific embodiments have been shown by way of example in the drawings and have been described in detail herein. However, it should be understood that the invention is not intended to be limited to the particular forms disclosed. Rather, the invention is to cover all modifications, equivalents, and alternatives falling within the spirit and scope of the invention as defined by the following appended claims. Indeed, the present techniques may not only be applied to pulse oximetry, but also to other physiological monitor outputs as well.

Claims

CLAIMSWhat is claimed is:
1. A method for processing a physiological signal, the method comprising the acts of: performing one or more multi-resolution decompositions on a physiological signal to generate high-passed components and low-passed components; and performing one or more morphological operations on at least one of the high-passed components or the low-passed components generated by the one or more of the respective multi-resolution decompositions.
2. The method of claim 1 , wherein the physiological signal is a waveform.
3. The method of claim 1, wherein the physiological signal is filtered.
4. The method of claim 3, wherein the physiological signal is median filtered.
5. The method of claim 1 , wherein the one or more multi-resolution decompositions comprise one or more wavelet decompositions.
6. The method of claim 1 , wherein the one or more morphological operations comprise at least one of an erosion or a dilation.
7. The method of claim 1 , wherein the physiological signal comprises a pulse oximetry signal.
8. The method of claim 1 , wherein the one or more multi-resolution decompositions and the one or more morphological operations are performed iteratively.
9. The method of claim 1 , comprising iteratively performing one or more multi- resolution decompositions on respectively generated low-passed components.
10. The method of claim 1 , wherein the one or more multi-resolution decompositions are implemented as a filter bank.
11. The method of claim 1 , comprising reconstructing an output waveform from one or more modified wavelet coefficients generated by the one or more morphological operations.
12. The method of claim 11 , wherein reconstructing the output waveform comprises performing an inverse wavelet transform of the one or more modified wavelet coefficients.
13. The method of claim 11 wherein the output waveform comprises a clean pulse oximetry signal.
14. One or more machine-readable media, comprising: a routine configured to perform one or more multi-resolution decompositions on a physiological signal to generate high-passed components and low-passed components; and a routine configured to perform one or more morphological operations on at least one of the high-passed components or the low-passed components generated by the one or more of the respective multi-resolution decompositions.
15. The one or more machine-readable media of claim 14, wherein the physiological signal is filtered.
16. The one or more machine-readable media of claim 14, wherein the one or more multi-resolution decompositions comprise one or more wavelet decompositions.
17. The one or more machine-readable media of claim 14, wherein the one or more morphological operations comprise at least one of an erosion or a dilation.
18. The one or more machine-readable media of claim 14, wherein the routine configured to perform the one or more multi-resolution decompositions and the routine for performing one or more morphological operations are implemented iteratively.
19. The one or more machine-readable media of claim 14, comprising a routine configured to iteratively perform one or more multi-resolution decompositions on respectively generated low-passed components.
20. The one or more machine-readable media of claim 14, wherein the one or more multi-resolution decompositions are implemented as a filter bank.
21. The one or more machine-readable media of claim 14, comprising a routine configured to reconstruct an output waveform from one or more modified wavelet coefficients generated by the one or more morphological operations.
22. The one or more machine-readable media of claim 21 , wherein the routine configured to reconstruct the output waveform performs an inverse wavelet transform of the one or more modified wavelet coefficients.
23. A physiological monitoring system, comprising: a sensor configured to generate a physiological signal; and a monitor configured to display one or more physiological parameters derived from a modified version of the physiological signal, wherein the modified version is generated by performing one or more multi-resolution decompositions on the physiological signal to generate high-passed components and low-passed components, performing one or more morphological operations on at least one of the high-passed components or the low-passed components generated by the one or more of the respective multi-resolution decompositions, and reconstructing the modified version from one or more modified wavelet coefficients generated by the one or more morphological operations.
24. The physiological monitoring system of claim 23, wherein the physiological signal is filtered.
25. The physiological monitoring system of claim 23, wherein the one or more multi-resolution decompositions comprise one or more wavelet decompositions.
26. The physiological monitoring system of claim 23, wherein the one or more morphological operations comprise at least one of an erosion or a dilation.
27. The physiological monitoring system of claim 23 , wherein the physiological signal comprises a pulse oximetry signal.
28. The physiological monitoring system of claim 23, wherein the one or more multi-resolution decompositions and the one or more morphological operations are performed iteratively.
29. The physiological monitoring system of claim 23 , wherein the one or more multi-resolution decompositions are implemented as a filter bank.
30. A physiological monitoring system, comprising: a sensor configured to generate a physiological signal; and a monitor configured to perform one or more multi-resolution decompositions on the physiological signal to generate high-passed components and low-passed components, and configured to perform one or more morphological operations on at least one of the high- passed components or the low-passed components generated by the one or more of the respective multi-resolution decompositions.
31. The physiological monitoring system of claim 30, wherein the monitor is further configured to filter the physiological signal.
32. The physiological monitoring system of claim 30, wherein the one or more multi-resolution decompositions comprise one or more wavelet decompositions.
33. The physiological monitoring system of claim 30, wherein the one or more morphological operations comprise at least one of an erosion or a dilation.
34. The physiological monitoring system of claim 30, wherein the monitor is configured to perform the one or more multi-resolution decompositions and the one or more morphological operations iteratively.
35. The physiological monitoring system of claim 30, wherein the monitor is configured to iteratively perform one or more multi-resolution decompositions on respectively generated low-passed components.
36. The physiological monitoring system of claim 30, wherein the one or more multi-resolution decompositions are implemented as a filter bank.
37. The physiological monitoring system of claim 30, wherein the monitor is configured to reconstruct an output waveform from one or more modified wavelet coefficients generated by the one or more morphological operations.
38. The physiological monitoring system of claim 37, wherein the monitor is configured apply an inverse wavelet transform to the one or more modified wavelet coefficients to reconstruct the output waveform.
PCT/US2006/038127 2005-09-29 2006-09-29 System and method for pre-processing waveforms WO2007041336A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/240,926 US7725146B2 (en) 2005-09-29 2005-09-29 System and method for pre-processing waveforms
US11/240,926 2005-09-29

Publications (1)

Publication Number Publication Date
WO2007041336A1 true WO2007041336A1 (en) 2007-04-12

Family

ID=37579146

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2006/038127 WO2007041336A1 (en) 2005-09-29 2006-09-29 System and method for pre-processing waveforms

Country Status (3)

Country Link
US (1) US7725146B2 (en)
TW (1) TW200722040A (en)
WO (1) WO2007041336A1 (en)

Families Citing this family (108)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7758503B2 (en) * 1997-01-27 2010-07-20 Lynn Lawrence A Microprocessor system for the analysis of physiologic and financial datasets
US9468378B2 (en) 1997-01-27 2016-10-18 Lawrence A. Lynn Airway instability detection system and method
US8932227B2 (en) 2000-07-28 2015-01-13 Lawrence A. Lynn System and method for CO2 and oximetry integration
US9042952B2 (en) 1997-01-27 2015-05-26 Lawrence A. Lynn System and method for automatic detection of a plurality of SPO2 time series pattern types
US20070191697A1 (en) * 2006-02-10 2007-08-16 Lynn Lawrence A System and method for SPO2 instability detection and quantification
US9521971B2 (en) 1997-07-14 2016-12-20 Lawrence A. Lynn System and method for automatic detection of a plurality of SPO2 time series pattern types
US20060195041A1 (en) 2002-05-17 2006-08-31 Lynn Lawrence A Centralized hospital monitoring system for automatically detecting upper airway instability and for preventing and aborting adverse drug reactions
US9053222B2 (en) 2002-05-17 2015-06-09 Lawrence A. Lynn Patient safety processor
US20080200775A1 (en) * 2007-02-20 2008-08-21 Lynn Lawrence A Maneuver-based plethysmographic pulse variation detection system and method
US7016715B2 (en) 2003-01-13 2006-03-21 Nellcorpuritan Bennett Incorporated Selection of preset filter parameters based on signal quality
JP4526532B2 (en) 2003-02-27 2010-08-18 ネルコア ピューリタン ベネット アイルランド Signal analysis and processing methods
US7725147B2 (en) 2005-09-29 2010-05-25 Nellcor Puritan Bennett Llc System and method for removing artifacts from waveforms
US7668579B2 (en) 2006-02-10 2010-02-23 Lynn Lawrence A System and method for the detection of physiologic response to stimulation
US20080200819A1 (en) * 2007-02-20 2008-08-21 Lynn Lawrence A Orthostasis detection system and method
US8369944B2 (en) 2007-06-06 2013-02-05 Zoll Medical Corporation Wearable defibrillator with audio input/output
US7974689B2 (en) 2007-06-13 2011-07-05 Zoll Medical Corporation Wearable medical treatment device with motion/position detection
US8140154B2 (en) 2007-06-13 2012-03-20 Zoll Medical Corporation Wearable medical treatment device
US8660799B2 (en) 2008-06-30 2014-02-25 Nellcor Puritan Bennett Ireland Processing and detecting baseline changes in signals
US8827917B2 (en) * 2008-06-30 2014-09-09 Nelleor Puritan Bennett Ireland Systems and methods for artifact detection in signals
US8077297B2 (en) 2008-06-30 2011-12-13 Nellcor Puritan Bennett Ireland Methods and systems for discriminating bands in scalograms
US20090324033A1 (en) * 2008-06-30 2009-12-31 Nellcor Puritan Bennett Ireland Signal Processing Systems and Methods for Determining Slope Using an Origin Point
US8295567B2 (en) 2008-06-30 2012-10-23 Nellcor Puritan Bennett Ireland Systems and methods for ridge selection in scalograms of signals
US7944551B2 (en) * 2008-06-30 2011-05-17 Nellcor Puritan Bennett Ireland Systems and methods for a wavelet transform viewer
US20100016692A1 (en) * 2008-07-15 2010-01-21 Nellcor Puritan Bennett Ireland Systems and methods for computing a physiological parameter using continuous wavelet transforms
US8660625B2 (en) * 2008-07-15 2014-02-25 Covidien Lp Signal processing systems and methods for analyzing multiparameter spaces to determine physiological states
US8226568B2 (en) * 2008-07-15 2012-07-24 Nellcor Puritan Bennett Llc Signal processing systems and methods using basis functions and wavelet transforms
US20100016676A1 (en) * 2008-07-15 2010-01-21 Nellcor Puritan Bennett Ireland Systems And Methods For Adaptively Filtering Signals
US8370080B2 (en) 2008-07-15 2013-02-05 Nellcor Puritan Bennett Ireland Methods and systems for determining whether to trigger an alarm
US8761855B2 (en) 2008-07-15 2014-06-24 Nellcor Puritan Bennett Ireland Systems and methods for determining oxygen saturation
US8285352B2 (en) 2008-07-15 2012-10-09 Nellcor Puritan Bennett Llc Systems and methods for identifying pulse rates
US8082110B2 (en) * 2008-07-15 2011-12-20 Nellcor Puritan Bennett Ireland Low perfusion signal processing systems and methods
US8679027B2 (en) 2008-07-15 2014-03-25 Nellcor Puritan Bennett Ireland Systems and methods for pulse processing
US8385675B2 (en) * 2008-07-15 2013-02-26 Nellcor Puritan Bennett Ireland Systems and methods for filtering a signal using a continuous wavelet transform
US8506498B2 (en) 2008-07-15 2013-08-13 Nellcor Puritan Bennett Ireland Systems and methods using induced perturbation to determine physiological parameters
US8358213B2 (en) 2008-07-15 2013-01-22 Covidien Lp Systems and methods for evaluating a physiological condition using a wavelet transform and identifying a band within a generated scalogram
US8696585B2 (en) * 2008-09-30 2014-04-15 Nellcor Puritan Bennett Ireland Detecting a probe-off event in a measurement system
US8410951B2 (en) 2008-09-30 2013-04-02 Covidien Lp Detecting a signal quality decrease in a measurement system
US20100087714A1 (en) * 2008-10-03 2010-04-08 Nellcor Puritan Bennett Ireland Reducing cross-talk in a measurement system
US9011347B2 (en) 2008-10-03 2015-04-21 Nellcor Puritan Bennett Ireland Methods and apparatus for determining breathing effort characteristics measures
US9155493B2 (en) 2008-10-03 2015-10-13 Nellcor Puritan Bennett Ireland Methods and apparatus for calibrating respiratory effort from photoplethysmograph signals
EP2348960A1 (en) * 2008-11-05 2011-08-03 Nellcor Puritan Bennett LLC System and method for facilitating observation of monitored physiologic data
US8538189B2 (en) * 2008-11-14 2013-09-17 Ati Technologies Ulc Image noise filter and method
US20100179391A1 (en) * 2009-01-15 2010-07-15 Lifesync Corporation Systems and methods for a wireless sensor proxy with feedback control
US8364225B2 (en) * 2009-05-20 2013-01-29 Nellcor Puritan Bennett Ireland Estimating transform values using signal estimates
US20100298728A1 (en) * 2009-05-20 2010-11-25 Nellcor Puritan Bennett Ireland Signal Processing Techniques For Determining Signal Quality Using A Wavelet Transform Ratio Surface
US8444570B2 (en) * 2009-06-09 2013-05-21 Nellcor Puritan Bennett Ireland Signal processing techniques for aiding the interpretation of respiration signals
US20100324827A1 (en) * 2009-06-18 2010-12-23 Nellcor Puritan Bennett Ireland Fluid Responsiveness Measure
US20100331716A1 (en) * 2009-06-26 2010-12-30 Nellcor Puritan Bennett Ireland Methods and apparatus for measuring respiratory function using an effort signal
US20100331715A1 (en) * 2009-06-30 2010-12-30 Nellcor Puritan Bennett Ireland Systems and methods for detecting effort events
US8636667B2 (en) * 2009-07-06 2014-01-28 Nellcor Puritan Bennett Ireland Systems and methods for processing physiological signals in wavelet space
US20110021892A1 (en) * 2009-07-23 2011-01-27 Nellcor Puritan Bennett Ireland Systems and methods for respiration monitoring
US20110021941A1 (en) * 2009-07-23 2011-01-27 Nellcor Puritan Bennett Ireland Systems and methods for respiration monitoring
US8478376B2 (en) * 2009-07-30 2013-07-02 Nellcor Puritan Bennett Ireland Systems and methods for determining physiological information using selective transform data
US8346333B2 (en) 2009-07-30 2013-01-01 Nellcor Puritan Bennett Ireland Systems and methods for estimating values of a continuous wavelet transform
US8594759B2 (en) * 2009-07-30 2013-11-26 Nellcor Puritan Bennett Ireland Systems and methods for resolving the continuous wavelet transform of a signal
US8628477B2 (en) * 2009-07-31 2014-01-14 Nellcor Puritan Bennett Ireland Systems and methods for non-invasive determination of blood pressure
US8755854B2 (en) 2009-07-31 2014-06-17 Nellcor Puritan Bennett Ireland Methods and apparatus for producing and using lightly filtered photoplethysmograph signals
EP2480997A2 (en) 2009-09-24 2012-08-01 Nellcor Puritan Bennett LLC Determination of a physiological parameter
US8923945B2 (en) * 2009-09-24 2014-12-30 Covidien Lp Determination of a physiological parameter
US8400149B2 (en) 2009-09-25 2013-03-19 Nellcor Puritan Bennett Ireland Systems and methods for gating an imaging device
US20110077484A1 (en) * 2009-09-30 2011-03-31 Nellcor Puritan Bennett Ireland Systems And Methods For Identifying Non-Corrupted Signal Segments For Use In Determining Physiological Parameters
US20110098933A1 (en) * 2009-10-26 2011-04-28 Nellcor Puritan Bennett Ireland Systems And Methods For Processing Oximetry Signals Using Least Median Squares Techniques
US9050043B2 (en) 2010-05-04 2015-06-09 Nellcor Puritan Bennett Ireland Systems and methods for wavelet transform scale-dependent multiple-archetyping
WO2011146448A1 (en) 2010-05-18 2011-11-24 Zoll Medical Corporation Wearable therapeutic device
US8834378B2 (en) 2010-07-30 2014-09-16 Nellcor Puritan Bennett Ireland Systems and methods for determining respiratory effort
US9427564B2 (en) 2010-12-16 2016-08-30 Zoll Medical Corporation Water resistant wearable medical device
US8897860B2 (en) 2011-03-25 2014-11-25 Zoll Medical Corporation Selection of optimal channel for rate determination
US8600486B2 (en) 2011-03-25 2013-12-03 Zoll Medical Corporation Method of detecting signal clipping in a wearable ambulatory medical device
US9113830B2 (en) 2011-05-31 2015-08-25 Nellcor Puritan Bennett Ireland Systems and methods for detecting and monitoring arrhythmias using the PPG
US9597022B2 (en) 2011-09-09 2017-03-21 Nellcor Puritan Bennett Ireland Venous oxygen saturation systems and methods
US9119597B2 (en) 2011-09-23 2015-09-01 Nellcor Puritan Bennett Ireland Systems and methods for determining respiration information from a photoplethysmograph
US9693709B2 (en) 2011-09-23 2017-07-04 Nellcot Puritan Bennett Ireland Systems and methods for determining respiration information from a photoplethysmograph
US9402554B2 (en) 2011-09-23 2016-08-02 Nellcor Puritan Bennett Ireland Systems and methods for determining respiration information from a photoplethysmograph
US9675274B2 (en) 2011-09-23 2017-06-13 Nellcor Puritan Bennett Ireland Systems and methods for determining respiration information from a photoplethysmograph
US8880576B2 (en) 2011-09-23 2014-11-04 Nellcor Puritan Bennett Ireland Systems and methods for determining respiration information from a photoplethysmograph
US8755871B2 (en) 2011-11-30 2014-06-17 Covidien Lp Systems and methods for detecting arrhythmia from a physiological signal
US9693736B2 (en) 2011-11-30 2017-07-04 Nellcor Puritan Bennett Ireland Systems and methods for determining respiration information using historical distribution
US9247896B2 (en) 2012-01-04 2016-02-02 Nellcor Puritan Bennett Ireland Systems and methods for determining respiration information using phase locked loop
US20150005591A1 (en) * 2012-01-31 2015-01-01 The Regents Of The University Of California Tissue to end tidal co2 monitor
US9878171B2 (en) 2012-03-02 2018-01-30 Zoll Medical Corporation Systems and methods for configuring a wearable medical monitoring and/or treatment device
US9179876B2 (en) 2012-04-30 2015-11-10 Nellcor Puritan Bennett Ireland Systems and methods for identifying portions of a physiological signal usable for determining physiological information
US11097107B2 (en) 2012-05-31 2021-08-24 Zoll Medical Corporation External pacing device with discomfort management
US10328266B2 (en) 2012-05-31 2019-06-25 Zoll Medical Corporation External pacing device with discomfort management
EP2854940B1 (en) 2012-05-31 2022-07-06 Zoll Medical Corporation Medical monitoring and treatment device with external pacing
WO2013181607A1 (en) 2012-05-31 2013-12-05 Zoll Medical Corporation Systems and methods for detecting health disorders
US10881310B2 (en) 2012-08-25 2021-01-05 The Board Of Trustees Of The Leland Stanford Junior University Motion artifact mitigation methods and devices for pulse photoplethysmography
US9560978B2 (en) 2013-02-05 2017-02-07 Covidien Lp Systems and methods for determining respiration information from a physiological signal using amplitude demodulation
US9687159B2 (en) 2013-02-27 2017-06-27 Covidien Lp Systems and methods for determining physiological information by identifying fiducial points in a physiological signal
US9554712B2 (en) 2013-02-27 2017-01-31 Covidien Lp Systems and methods for generating an artificial photoplethysmograph signal
US9974468B2 (en) 2013-03-15 2018-05-22 Covidien Lp Systems and methods for identifying a medically monitored patient
CN105492070A (en) 2013-06-28 2016-04-13 卓尔医疗公司 Systems and methods of delivering therapy using an ambulatory medical device
US10022068B2 (en) 2013-10-28 2018-07-17 Covidien Lp Systems and methods for detecting held breath events
WO2015105787A1 (en) 2014-01-07 2015-07-16 Covidien Lp Apnea analysis system and method
US9955894B2 (en) 2014-01-28 2018-05-01 Covidien Lp Non-stationary feature relationship parameters for awareness monitoring
WO2015127281A1 (en) 2014-02-20 2015-08-27 Covidien Lp Systems and methods for filtering autocorrelation peaks and detecting harmonics
TWI552004B (en) * 2015-03-12 2016-10-01 國立交通大學 Signal decomposition method and electronic apparatus using the same
US10835449B2 (en) 2015-03-30 2020-11-17 Zoll Medical Corporation Modular components for medical devices
PL3693057T3 (en) 2015-11-23 2023-02-20 Zoll Medical Corporation Garments for wearable medical devices
US11617538B2 (en) 2016-03-14 2023-04-04 Zoll Medical Corporation Proximity based processing systems and methods
US11009870B2 (en) 2017-06-06 2021-05-18 Zoll Medical Corporation Vehicle compatible ambulatory defibrillator
US10646707B2 (en) 2017-11-30 2020-05-12 Zoll Medical Corporation Medical devices with rapid sensor recovery
US10960213B2 (en) 2018-03-12 2021-03-30 Zoll Medical Corporation Verification of cardiac arrhythmia prior to therapeutic stimulation
US11890461B2 (en) 2018-09-28 2024-02-06 Zoll Medical Corporation Adhesively coupled wearable medical device
US11568984B2 (en) 2018-09-28 2023-01-31 Zoll Medical Corporation Systems and methods for device inventory management and tracking
WO2020139880A1 (en) 2018-12-28 2020-07-02 Zoll Medical Corporation Wearable medical device response mechanisms and methods of use
CN213609416U (en) 2019-10-09 2021-07-06 Zoll医疗公司 Treatment electrode part and wearable treatment device
CN113517877A (en) * 2021-04-30 2021-10-19 华中科技大学 Steel wire rope online detection signal noise reduction method and system based on generalized morphological filtering
CN113749655B (en) * 2021-11-08 2022-03-08 芯原微电子(南京)有限公司 Method and device for detecting blood oxygen saturation, electronic equipment and storage medium

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040054281A1 (en) * 2000-05-11 2004-03-18 Dan Adam Wavelet depulsing of ultrasound echo sequences
US20040193065A1 (en) * 2003-03-31 2004-09-30 Houben Richard P.M. Biomedical signal denoising techniques

Family Cites Families (205)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3638640A (en) 1967-11-01 1972-02-01 Robert F Shaw Oximeter and method for in vivo determination of oxygen saturation in blood using three or more different wavelengths
US4938218A (en) 1983-08-30 1990-07-03 Nellcor Incorporated Perinatal pulse oximetry sensor
US4714341A (en) 1984-02-23 1987-12-22 Minolta Camera Kabushiki Kaisha Multi-wavelength oximeter having a means for disregarding a poor signal
US4911167A (en) 1985-06-07 1990-03-27 Nellcor Incorporated Method and apparatus for detecting optical pulses
US4936679A (en) 1985-11-12 1990-06-26 Becton, Dickinson And Company Optical fiber transducer driving and measuring circuit and method for using same
US4913150A (en) 1986-08-18 1990-04-03 Physio-Control Corporation Method and apparatus for the automatic calibration of signals employed in oximetry
US4805623A (en) 1987-09-04 1989-02-21 Vander Corporation Spectrophotometric method for quantitatively determining the concentration of a dilute component in a light- or other radiation-scattering environment
US4807631A (en) 1987-10-09 1989-02-28 Critikon, Inc. Pulse oximetry system
EP0315040B1 (en) 1987-11-02 1993-01-27 Sumitomo Electric Industries Limited Bio-photosensor
JPH0288041A (en) 1988-09-24 1990-03-28 Misawahoomu Sogo Kenkyusho:Kk Finger tip pulse wave sensor
US5873821A (en) 1992-05-18 1999-02-23 Non-Invasive Technology, Inc. Lateralization spectrophotometer
US4972331A (en) 1989-02-06 1990-11-20 Nim, Inc. Phase modulated spectrophotometry
US5564417A (en) 1991-01-24 1996-10-15 Non-Invasive Technology, Inc. Pathlength corrected oximeter and the like
CA1331483C (en) 1988-11-02 1994-08-16 Britton Chance User-wearable hemoglobinometer for measuring the metabolic condition of a subject
US5122974A (en) 1989-02-06 1992-06-16 Nim, Inc. Phase modulated spectrophotometry
EP0374668A3 (en) 1988-12-16 1992-02-05 A.W. Faber - Castell GmbH & Co. Fluorescent marking fluid
US5553614A (en) 1988-12-21 1996-09-10 Non-Invasive Technology, Inc. Examination of biological tissue using frequency domain spectroscopy
US5119815A (en) 1988-12-21 1992-06-09 Nim, Incorporated Apparatus for determining the concentration of a tissue pigment of known absorbance, in vivo, using the decay characteristics of scintered electromagnetic radiation
US5028787A (en) 1989-01-19 1991-07-02 Futrex, Inc. Non-invasive measurement of blood glucose
US6708048B1 (en) 1989-02-06 2004-03-16 Non-Invasive Technology, Inc. Phase modulation spectrophotometric apparatus
US6183414B1 (en) 1999-04-26 2001-02-06 Michael S. Wysor Technique for restoring plasticity to tissues of a male or female organ
US5483646A (en) 1989-09-29 1996-01-09 Kabushiki Kaisha Toshiba Memory access control method and system for realizing the same
US5190038A (en) 1989-11-01 1993-03-02 Novametrix Medical Systems, Inc. Pulse oximeter with improved accuracy and response time
DE3938759A1 (en) 1989-11-23 1991-05-29 Philips Patentverwaltung NON-INVASIVE OXIMETER ARRANGEMENT
US5372136A (en) 1990-10-06 1994-12-13 Noninvasive Medical Technology Corporation System and method for noninvasive hematocrit monitoring
US6681128B2 (en) 1990-10-06 2004-01-20 Hema Metrics, Inc. System for noninvasive hematocrit monitoring
US6246894B1 (en) 1993-02-01 2001-06-12 In-Line Diagnostics Corporation System and method for measuring blood urea nitrogen, blood osmolarity, plasma free hemoglobin and tissue water content
US6266546B1 (en) 1990-10-06 2001-07-24 In-Line Diagnostics Corporation System for noninvasive hematocrit monitoring
MX9702434A (en) 1991-03-07 1998-05-31 Masimo Corp Signal processing apparatus.
WO1992015955A1 (en) 1991-03-07 1992-09-17 Vital Signals, Inc. Signal processing apparatus and method
US6580086B1 (en) 1999-08-26 2003-06-17 Masimo Corporation Shielded optical probe and method
US5638818A (en) 1991-03-21 1997-06-17 Masimo Corporation Low noise optical probe
US5995855A (en) 1998-02-11 1999-11-30 Masimo Corporation Pulse oximetry sensor adapter
DE4138702A1 (en) 1991-03-22 1992-09-24 Madaus Medizin Elektronik METHOD AND DEVICE FOR THE DIAGNOSIS AND QUANTITATIVE ANALYSIS OF APNOE AND FOR THE SIMULTANEOUS DETERMINATION OF OTHER DISEASES
US6549795B1 (en) 1991-05-16 2003-04-15 Non-Invasive Technology, Inc. Spectrophotometer for tissue examination
US5246003A (en) 1991-08-28 1993-09-21 Nellcor Incorporated Disposable pulse oximeter sensor
US6987994B1 (en) 1991-09-03 2006-01-17 Datex-Ohmeda, Inc. Pulse oximetry SpO2 determination
US5247931A (en) 1991-09-16 1993-09-28 Mine Safety Appliances Company Diagnostic sensor clasp utilizing a slot, pivot and spring hinge mechanism
DE59209492D1 (en) 1992-01-25 1998-10-15 Alsthom Cge Alcatel Procedures to facilitate the operation of end devices in telecommunications systems
US5385143A (en) 1992-02-06 1995-01-31 Nihon Kohden Corporation Apparatus for measuring predetermined data of living tissue
US5297548A (en) 1992-02-07 1994-03-29 Ohmeda Inc. Arterial blood monitoring probe
JP3249517B2 (en) 1992-02-28 2002-01-21 キャデル、テオドール・イー Non-invasive device and method for determining the concentration of various components of blood or tissue
US5263244A (en) 1992-04-17 1993-11-23 Gould Inc. Method of making a flexible printed circuit sensor assembly for detecting optical pulses
JP3170866B2 (en) 1992-04-24 2001-05-28 株式会社ノーリツ 1 can 2 circuit type instant heating type heat exchanger
EP0572684B1 (en) 1992-05-15 1996-07-03 Hewlett-Packard GmbH Medical sensor
US6785568B2 (en) 1992-05-18 2004-08-31 Non-Invasive Technology Inc. Transcranial examination of the brain
US5355880A (en) 1992-07-06 1994-10-18 Sandia Corporation Reliable noninvasive measurement of blood gases
US6222189B1 (en) 1992-07-15 2001-04-24 Optix, Lp Methods of enhancing optical signals by mechanical manipulation in non-invasive testing
US20050062609A9 (en) 1992-08-19 2005-03-24 Lynn Lawrence A. Pulse oximetry relational alarm system for early recognition of instability and catastrophic occurrences
US5680857A (en) 1992-08-28 1997-10-28 Spacelabs Medical, Inc. Alignment guide system for transmissive pulse oximetry sensors
EP1491135A3 (en) 1993-04-12 2005-09-07 Hema Metrics, Inc. Method and apparatus for monitoring blood constituents
US5521851A (en) 1993-04-26 1996-05-28 Nihon Kohden Corporation Noise reduction method and apparatus
US7376453B1 (en) 1993-10-06 2008-05-20 Masimo Corporation Signal processing apparatus
CA2155932A1 (en) 1993-12-14 1995-06-22 Tadakazu Yamauchi Medical measuring apparatus
US5645059A (en) 1993-12-17 1997-07-08 Nellcor Incorporated Medical sensor with modulated encoding scheme
JP3238813B2 (en) 1993-12-20 2001-12-17 テルモ株式会社 Pulse oximeter
JP3464697B2 (en) 1993-12-21 2003-11-10 興和株式会社 Oxygen saturation meter
US5995859A (en) 1994-02-14 1999-11-30 Nihon Kohden Corporation Method and apparatus for accurately measuring the saturated oxygen in arterial blood by substantially eliminating noise from the measurement signal
US5575284A (en) 1994-04-01 1996-11-19 University Of South Florida Portable pulse oximeter
DE4423597C1 (en) 1994-07-06 1995-08-10 Hewlett Packard Gmbh Pulsoximetric ear sensor
US8019400B2 (en) 1994-10-07 2011-09-13 Masimo Corporation Signal processing apparatus
US5692503A (en) 1995-03-10 1997-12-02 Kuenstner; J. Todd Method for noninvasive (in-vivo) total hemoglobin, oxyhemogolobin, deoxyhemoglobin, carboxyhemoglobin and methemoglobin concentration determination
US7035697B1 (en) 1995-05-30 2006-04-25 Roy-G-Biv Corporation Access control systems and methods for motion control
US5758644A (en) 1995-06-07 1998-06-02 Masimo Corporation Manual and automatic probe calibration
US5645060A (en) 1995-06-14 1997-07-08 Nellcor Puritan Bennett Incorporated Method and apparatus for removing artifact and noise from pulse oximetry
US5588427A (en) * 1995-11-20 1996-12-31 Spacelabs Medical, Inc. Enhancement of physiological signals using fractal analysis
US5995856A (en) 1995-11-22 1999-11-30 Nellcor, Incorporated Non-contact optical monitoring of physiological parameters
SE9600322L (en) 1996-01-30 1997-07-31 Hoek Instr Ab Sensor for pulse oximetry with fiber optic signal transmission
DE59704665D1 (en) 1996-04-01 2001-10-25 Linde Medical Sensors Ag Basel DETECTION OF INTERFERENCE SIGNALS IN PULSOXYMETRIC MEASUREMENT
US5842981A (en) 1996-07-17 1998-12-01 Criticare Systems, Inc. Direct to digital oximeter
US6163715A (en) 1996-07-17 2000-12-19 Criticare Systems, Inc. Direct to digital oximeter and method for calculating oxygenation levels
US6544193B2 (en) 1996-09-04 2003-04-08 Marcio Marc Abreu Noninvasive measurement of chemical substances
US5830139A (en) 1996-09-04 1998-11-03 Abreu; Marcio M. Tonometer system for measuring intraocular pressure by applanation and/or indentation
US6120460A (en) 1996-09-04 2000-09-19 Abreu; Marcio Marc Method and apparatus for signal acquisition, processing and transmission for evaluation of bodily functions
US5871442A (en) 1996-09-10 1999-02-16 International Diagnostics Technologies, Inc. Photonic molecular probe
US6081742A (en) 1996-09-10 2000-06-27 Seiko Epson Corporation Organism state measuring device and relaxation instructing device
DE19640807A1 (en) 1996-10-02 1997-09-18 Siemens Ag Noninvasive optical detection of oxygen supply to e.g. brain or liver
US5830136A (en) 1996-10-31 1998-11-03 Nellcor Puritan Bennett Incorporated Gel pad optical sensor
US9468378B2 (en) 1997-01-27 2016-10-18 Lawrence A. Lynn Airway instability detection system and method
US8932227B2 (en) 2000-07-28 2015-01-13 Lawrence A. Lynn System and method for CO2 and oximetry integration
US9042952B2 (en) 1997-01-27 2015-05-26 Lawrence A. Lynn System and method for automatic detection of a plurality of SPO2 time series pattern types
US6487439B1 (en) 1997-03-17 2002-11-26 Victor N. Skladnev Glove-mounted hybrid probe for tissue type recognition
US5810014A (en) * 1997-03-25 1998-09-22 Davis; Dennis W. Method and system for detection of physiological conditions
US6002952A (en) 1997-04-14 1999-12-14 Masimo Corporation Signal processing apparatus and method
AUPO676397A0 (en) 1997-05-13 1997-06-05 Dunlop, Colin Method and apparatus for monitoring haemodynamic function
CA2303803A1 (en) 1997-06-17 1998-12-23 Respironics, Inc. Fetal oximetry system and sensor
AU7934498A (en) 1997-06-27 1999-01-19 Toa Medical Electronics Co., Ltd. Living body inspecting apparatus and noninvasive blood analyzer using the same
FI973454A (en) 1997-08-22 1999-02-23 Instrumentarium Oy A resilient device in a measuring sensor for observing the properties of living tissue
DE69833656T2 (en) 1997-08-26 2006-08-17 Seiko Epson Corp. DEVICE FOR DIAGNOSIS OF PULSE WAVES
DE69700384T2 (en) 1997-12-22 1999-11-25 Hewlett Packard Co Telemetry system, in particular for medical purposes
JP3567319B2 (en) 1997-12-26 2004-09-22 日本光電工業株式会社 Probe for pulse oximeter
DE69940053D1 (en) 1998-02-05 2009-01-22 Hema Metrics Inc METHOD AND DEVICE FOR NON-INVASIVE OBSERVATION OF BLOOD COMPONENTS
JP3576851B2 (en) 1998-03-23 2004-10-13 キヤノン株式会社 Liquid crystal display, video camera
US6662030B2 (en) 1998-05-18 2003-12-09 Abbott Laboratories Non-invasive sensor having controllable temperature feature
US6094592A (en) 1998-05-26 2000-07-25 Nellcor Puritan Bennett, Inc. Methods and apparatus for estimating a physiological parameter using transforms
IL124787A0 (en) 1998-06-07 1999-01-26 Itamar Medical C M 1997 Ltd Pressure applicator devices particularly useful for non-invasive detection of medical conditions
US5920263A (en) 1998-06-11 1999-07-06 Ohmeda, Inc. De-escalation of alarm priorities in medical devices
US6842635B1 (en) 1998-08-13 2005-01-11 Edwards Lifesciences Llc Optical device
US6990365B1 (en) 1998-07-04 2006-01-24 Edwards Lifesciences Apparatus for measurement of blood analytes
US6671526B1 (en) 1998-07-17 2003-12-30 Nihon Kohden Corporation Probe and apparatus for determining concentration of light-absorbing materials in living tissue
JP2000083933A (en) 1998-07-17 2000-03-28 Nippon Koden Corp Instrument for measuring concentration of light absorptive material in vital tissue
US6949081B1 (en) 1998-08-26 2005-09-27 Non-Invasive Technology, Inc. Sensing and interactive drug delivery
US6064898A (en) 1998-09-21 2000-05-16 Essential Medical Devices Non-invasive blood component analyzer
US7991448B2 (en) 1998-10-15 2011-08-02 Philips Electronics North America Corporation Method, apparatus, and system for removing motion artifacts from measurements of bodily parameters
US6519486B1 (en) 1998-10-15 2003-02-11 Ntc Technology Inc. Method, apparatus and system for removing motion artifacts from measurements of bodily parameters
US6393311B1 (en) 1998-10-15 2002-05-21 Ntc Technology Inc. Method, apparatus and system for removing motion artifacts from measurements of bodily parameters
US6352502B1 (en) 1998-12-03 2002-03-05 Lightouch Medical, Inc. Methods for obtaining enhanced spectroscopic information from living tissue, noninvasive assessment of skin condition and detection of skin abnormalities
US6684090B2 (en) 1999-01-07 2004-01-27 Masimo Corporation Pulse oximetry data confidence indicator
US6606511B1 (en) 1999-01-07 2003-08-12 Masimo Corporation Pulse oximetry pulse indicator
US6658276B2 (en) 1999-01-25 2003-12-02 Masimo Corporation Pulse oximeter user interface
EP1148809B1 (en) * 1999-01-25 2007-11-14 Masimo Corporation Universal/upgrading pulse oximeter
US6438399B1 (en) 1999-02-16 2002-08-20 The Children's Hospital Of Philadelphia Multi-wavelength frequency domain near-infrared cerebral oximeter
US6360114B1 (en) 1999-03-25 2002-03-19 Masimo Corporation Pulse oximeter probe-off detector
US6654623B1 (en) * 1999-06-10 2003-11-25 Koninklijke Philips Electronics N.V. Interference suppression for measuring signals with periodic wanted signals
US6587704B1 (en) 1999-06-16 2003-07-01 Orsense Ltd. Method for non-invasive optical measurements of blood parameters
US6675029B2 (en) 1999-07-22 2004-01-06 Sensys Medical, Inc. Apparatus and method for quantification of tissue hydration using diffuse reflectance spectroscopy
US7904139B2 (en) 1999-08-26 2011-03-08 Non-Invasive Technology Inc. Optical examination of biological tissue using non-contact irradiation and detection
US6618042B1 (en) 1999-10-28 2003-09-09 Gateway, Inc. Display brightness control method and apparatus for conserving battery power
CA2290083A1 (en) 1999-11-19 2001-05-19 Linde Medical Sensors Ag. Device for the combined measurement of the arterial oxygen saturation and the transcutaneous co2 partial pressure of an ear lobe
JP2001149349A (en) 1999-11-26 2001-06-05 Nippon Koden Corp Sensor for living body
US6415236B2 (en) 1999-11-30 2002-07-02 Nihon Kohden Corporation Apparatus for determining concentrations of hemoglobins
US6622095B2 (en) 1999-11-30 2003-09-16 Nihon Kohden Corporation Apparatus for determining concentrations of hemoglobins
US6711424B1 (en) 1999-12-22 2004-03-23 Orsense Ltd. Method of optical measurement for determing various parameters of the patient's blood
US6419671B1 (en) 1999-12-23 2002-07-16 Visx, Incorporated Optical feedback system for vision correction
US6594513B1 (en) 2000-01-12 2003-07-15 Paul D. Jobsis Method and apparatus for determining oxygen saturation of blood in body organs
EP1257195A2 (en) 2000-02-18 2002-11-20 Argose, Inc. Multivariate analysis of green to ultraviolet spectra of cell and tissue samples
IL135077A0 (en) 2000-03-15 2001-05-20 Orsense Ltd A probe for use in non-invasive measurements of blood related parameters
ES2392818T3 (en) 2000-04-17 2012-12-14 Nellcor Puritan Bennett Llc Pulse oximeter sensor with section function
US6449501B1 (en) * 2000-05-26 2002-09-10 Ob Scientific, Inc. Pulse oximeter with signal sonification
US6889153B2 (en) 2001-08-09 2005-05-03 Thomas Dietiker System and method for a self-calibrating non-invasive sensor
IL138683A0 (en) 2000-09-25 2001-10-31 Vital Medical Ltd Apparatus and method for monitoring tissue vitality parameters
IL138884A (en) 2000-10-05 2006-07-05 Conmed Corp Pulse oximeter and a method of its operation
US6466809B1 (en) 2000-11-02 2002-10-15 Datex-Ohmeda, Inc. Oximeter sensor having laminated housing with flat patient interface surface
US6505133B1 (en) 2000-11-15 2003-01-07 Datex-Ohmeda, Inc. Simultaneous signal attenuation measurements utilizing code division multiplexing
US6501974B2 (en) 2001-01-22 2002-12-31 Datex-Ohmeda, Inc. Compensation of human variability in pulse oximetry
US6591122B2 (en) 2001-03-16 2003-07-08 Nellcor Puritan Bennett Incorporated Device and method for monitoring body fluid and electrolyte disorders
US7239902B2 (en) 2001-03-16 2007-07-03 Nellor Puritan Bennett Incorporated Device and method for monitoring body fluid and electrolyte disorders
US6606509B2 (en) 2001-03-16 2003-08-12 Nellcor Puritan Bennett Incorporated Method and apparatus for improving the accuracy of noninvasive hematocrit measurements
US6898451B2 (en) 2001-03-21 2005-05-24 Minformed, L.L.C. Non-invasive blood analyte measuring system and method utilizing optical absorption
US20020156354A1 (en) 2001-04-20 2002-10-24 Larson Eric Russell Pulse oximetry sensor with improved spring
US6801798B2 (en) 2001-06-20 2004-10-05 Purdue Research Foundation Body-member-illuminating pressure cuff for use in optical noninvasive measurement of blood parameters
EP2319401B1 (en) 2001-06-22 2012-08-22 Nellcor Puritan Bennett Ireland Wavelet-based analysis of pulse oximetry signals
SG126677A1 (en) 2001-06-26 2006-11-29 Meng Ting Choon Method and device for measuring blood sugar level
US6697658B2 (en) 2001-07-02 2004-02-24 Masimo Corporation Low power pulse oximeter
DE10139379A1 (en) 2001-08-10 2003-03-06 Siemens Ag Inductive motion sensor has sensor coils beside permanent magnet field generator
US6654621B2 (en) 2001-08-29 2003-11-25 Bci, Inc. Finger oximeter with finger grip suspension system
US6668183B2 (en) 2001-09-11 2003-12-23 Datex-Ohmeda, Inc. Diode detection circuit
IL145445A (en) 2001-09-13 2006-12-31 Conmed Corp Signal processing method and device for signal-to-noise improvement
US6701170B2 (en) 2001-11-02 2004-03-02 Nellcor Puritan Bennett Incorporated Blind source separation of pulse oximetry signals
US7162306B2 (en) 2001-11-19 2007-01-09 Medtronic Physio - Control Corp. Internal medical device communication bus
JP3709836B2 (en) 2001-11-20 2005-10-26 コニカミノルタセンシング株式会社 Blood component measuring device
JP2003194714A (en) 2001-12-28 2003-07-09 Omega Wave Kk Measuring apparatus for blood amount in living-body tissue
JP2003210438A (en) 2002-01-22 2003-07-29 Tyco Healthcare Japan Inc Adapter for oximeter
US6822564B2 (en) 2002-01-24 2004-11-23 Masimo Corporation Parallel measurement alarm processor
US7020507B2 (en) 2002-01-31 2006-03-28 Dolphin Medical, Inc. Separating motion from cardiac signals using second order derivative of the photo-plethysmogram and fast fourier transforms
DE60315596T2 (en) 2002-01-31 2008-05-15 Loughborough University Enterprises Ltd., Loughborough VENOUS PULSE OXIMETRY
CA2475726C (en) 2002-02-14 2010-02-09 Toshinori Kato Apparatus for evaluating biological function
WO2003071939A1 (en) 2002-02-22 2003-09-04 Masimo Corporation Active pulse spectraphotometry
EP1485015A1 (en) 2002-02-22 2004-12-15 Datex-Ohmeda, Inc. Cepstral domain pulse oximetry
US20050177034A1 (en) 2002-03-01 2005-08-11 Terry Beaumont Ear canal sensing device
US6863652B2 (en) 2002-03-13 2005-03-08 Draeger Medical Systems, Inc. Power conserving adaptive control system for generating signal in portable medical devices
JP2003275192A (en) 2002-03-25 2003-09-30 Citizen Watch Co Ltd Blood analyzer
DE10213692B4 (en) 2002-03-27 2013-05-23 Weinmann Diagnostics Gmbh & Co. Kg Method for controlling a device and device for measuring ingredients in the blood
US6690958B1 (en) 2002-05-07 2004-02-10 Nostix Llc Ultrasound-guided near infrared spectrophotometer
US6711425B1 (en) 2002-05-28 2004-03-23 Ob Scientific, Inc. Pulse oximeter with calibration stabilization
JP2003339678A (en) 2002-05-30 2003-12-02 Minolta Co Ltd Instrument for measuring blood state
JP4040913B2 (en) 2002-06-07 2008-01-30 株式会社パルメディカル Noninvasive arteriovenous oxygen saturation measuring device
US6909912B2 (en) 2002-06-20 2005-06-21 University Of Florida Non-invasive perfusion monitor and system, specially configured oximeter probes, methods of using same, and covers for probes
US7024235B2 (en) 2002-06-20 2006-04-04 University Of Florida Research Foundation, Inc. Specially configured nasal pulse oximeter/photoplethysmography probes, and combined nasal probe/cannula, selectively with sampler for capnography, and covering sleeves for same
JP4395068B2 (en) 2002-07-15 2010-01-06 イタマール メディカル リミテッド Body surface probe, apparatus, and method for non-invasive detection of medical conditions
US7133711B2 (en) 2002-08-07 2006-11-07 Orsense, Ltd. Method and system for decomposition of multiple channel signals
JP2004113353A (en) 2002-09-25 2004-04-15 Citizen Watch Co Ltd Blood analyzer
JP2004135854A (en) 2002-10-17 2004-05-13 Nippon Colin Co Ltd Reflection type photoelectric pulse wave detector and reflection type oxymeter
JP2004202190A (en) 2002-11-08 2004-07-22 Minolta Co Ltd Biological information measuring device
WO2004047631A2 (en) 2002-11-22 2004-06-10 Masimo Laboratories, Inc. Blood parameter measurement system
JP3944448B2 (en) 2002-12-18 2007-07-11 浜松ホトニクス株式会社 Blood measuring device
JP4284674B2 (en) 2003-01-31 2009-06-24 日本光電工業株式会社 Absorbent concentration measuring device in blood
WO2004069046A1 (en) 2003-02-05 2004-08-19 Philips Intellectual Property & Standards Gmbh Finger medical sensor
JP2004248819A (en) 2003-02-19 2004-09-09 Citizen Watch Co Ltd Blood analyzer
JP4526532B2 (en) * 2003-02-27 2010-08-18 ネルコア ピューリタン ベネット アイルランド Signal analysis and processing methods
JP2004290545A (en) 2003-03-28 2004-10-21 Citizen Watch Co Ltd Blood analyzer
US6947780B2 (en) 2003-03-31 2005-09-20 Dolphin Medical, Inc. Auditory alarms for physiological data monitoring
US7477571B2 (en) 2003-04-03 2009-01-13 Sri International Method for detecting vibrations in a biological organism using real-time vibration imaging
KR100571811B1 (en) 2003-05-09 2006-04-17 삼성전자주식회사 Ear type measurement apparatus for bio signal
IL155955A0 (en) 2003-05-15 2003-12-23 Widemed Ltd Adaptive prediction of changes of physiological/pathological states using processing of biomedical signal
US7047056B2 (en) 2003-06-25 2006-05-16 Nellcor Puritan Bennett Incorporated Hat-based oximeter sensor
KR100675555B1 (en) 2003-07-07 2007-01-29 유선국 Pulse oximeter and thereof method
WO2005020120A2 (en) 2003-08-20 2005-03-03 Koninklijke Philips Electronics N.V. A system and method for detecting signal artifacts
WO2005020798A2 (en) 2003-08-27 2005-03-10 Datex-Ohmeda, Inc. Multi-domain motion estimation and plethysmographic recognition using fuzzy neural-nets
US7373193B2 (en) 2003-11-07 2008-05-13 Masimo Corporation Pulse oximetry data capture system
US20050113651A1 (en) 2003-11-26 2005-05-26 Confirma, Inc. Apparatus and method for surgical planning and treatment monitoring
US20050267346A1 (en) 2004-01-30 2005-12-01 3Wave Optics, Llc Non-invasive blood component measurement system
CA2555807A1 (en) 2004-02-12 2005-08-25 Biopeak Corporation Non-invasive method and apparatus for determining a physiological parameter
US7277741B2 (en) 2004-03-09 2007-10-02 Nellcor Puritan Bennett Incorporated Pulse oximetry motion artifact rejection using near infrared absorption by water
JP4191642B2 (en) 2004-04-02 2008-12-03 三菱電機株式会社 Transflective liquid crystal display device and manufacturing method thereof
US20050228248A1 (en) 2004-04-07 2005-10-13 Thomas Dietiker Clip-type sensor having integrated biasing and cushioning means
US7551950B2 (en) 2004-06-29 2009-06-23 O2 Medtech, Inc,. Optical apparatus and method of use for non-invasive tomographic scan of biological tissues
US7343186B2 (en) 2004-07-07 2008-03-11 Masimo Laboratories, Inc. Multi-wavelength physiological monitor
CN103083768B (en) 2004-10-06 2016-07-06 瑞思迈有限公司 Method and apparatus for non-invasive monitoring of respiratory parameters in sleep disordered breathing
US7578793B2 (en) 2004-11-22 2009-08-25 Widemed Ltd. Sleep staging based on cardio-respiratory signals
GB2424270A (en) 2005-03-14 2006-09-20 Spectrum Medical Llp Optical monitoring of predetermined substances in blood
US7548771B2 (en) 2005-03-31 2009-06-16 Nellcor Puritan Bennett Llc Pulse oximetry sensor and technique for using the same on a distal region of a patient's digit
KR100716824B1 (en) 2005-04-28 2007-05-09 삼성전기주식회사 Printed circuit board with embedded capacitors using hybrid materials, and manufacturing process thereof
US20060293574A1 (en) 2005-06-28 2006-12-28 Norris Mark A Separating oximeter signal components based on color
US7515949B2 (en) * 2005-06-29 2009-04-07 General Electric Company Wavelet transform of a plethysmographic signal

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040054281A1 (en) * 2000-05-11 2004-03-18 Dan Adam Wavelet depulsing of ultrasound echo sequences
US20040193065A1 (en) * 2003-03-31 2004-09-30 Houben Richard P.M. Biomedical signal denoising techniques

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
DONOHO D L ET AL: "Robust nonlinear wavelet transform based on median-interpolation", SIGNALS, SYSTEMS & COMPUTERS, 1997. CONFERENCE RECORD OF THE THIRTY-FIRST ASILOMAR CONFERENCE ON PACIFIC GROVE, CA, USA 2-5 NOV. 1997, LOS ALAMITOS, CA, USA,IEEE COMPUT. SOC, US, vol. 1, 2 November 1997 (1997-11-02), pages 75 - 79, XP010280825, ISBN: 0-8186-8316-3 *
HENK J A M HEIJMANS H J A M ET AL: "Nonlinear Multiresolution Signal Decomposition Schemes-Part II: Morphological Wavelets", IEEE TRANSACTIONS ON IMAGE PROCESSING, IEEE SERVICE CENTER, PISCATAWAY, NJ, US, vol. 9, no. 11, November 2000 (2000-11-01), XP011025684, ISSN: 1057-7149 *
JOHN GOUTSIAS ET AL: "Nonlinear Multiresolution Signal Decomposition Schemes-Part I: Morphological Pyramids", IEEE TRANSACTIONS ON IMAGE PROCESSING, IEEE SERVICE CENTER, PISCATAWAY, NJ, US, vol. 9, no. 11, November 2000 (2000-11-01), XP011025682, ISSN: 1057-7149 *
MACEY K E ET AL: "Wavelet median denoising of ultrasound images", PROCEEDINGS OF THE SPIE, SPIE, BELLINGHAM, VA, US, vol. 4684, 24 February 2002 (2002-02-24), pages 1151 - 1160, XP007901521, ISSN: 0277-786X *
PAULUS D., HORNEGGER, J (ED): "Applied Pattern Recognition", 1997, FRIEDR. VIEWEG & SOHN VERLAGSGESELLSCHAFT MBH, WIESBADEN, XP002414443 *
RUSCH T L ET AL: "Signal processing methods for pulse oximetry", COMPUTERS IN BIOLOGY AND MEDICINE, NEW YORK, NY, US, vol. 26, no. 2, March 1996 (1996-03-01), pages 143 - 159, XP004532247, ISSN: 0010-4825 *
SUN Y ET AL: "ECG signal conditioning by morphological filtering", COMPUTERS IN BIOLOGY AND MEDICINE, NEW YORK, NY, US, vol. 32, no. 6, November 2002 (2002-11-01), pages 465 - 479, XP004532411, ISSN: 0010-4825 *

Also Published As

Publication number Publication date
US20070073120A1 (en) 2007-03-29
US7725146B2 (en) 2010-05-25
TW200722040A (en) 2007-06-16

Similar Documents

Publication Publication Date Title
US7725146B2 (en) System and method for pre-processing waveforms
US7725147B2 (en) System and method for removing artifacts from waveforms
US6701170B2 (en) Blind source separation of pulse oximetry signals
US8855749B2 (en) Determination of a physiological parameter
US8594759B2 (en) Systems and methods for resolving the continuous wavelet transform of a signal
WO2010128275A1 (en) Selection of signal regions for parameter extraction
US20090326351A1 (en) Signal Processing Mirroring Technique
WO2010001249A1 (en) Concatenated scalograms
WO2010001246A2 (en) Systems and methods for artifact detection in signals
WO2014043255A1 (en) Methods and systems for processing physiological signals
WO2010038123A1 (en) Detecting a probe off event in a measurement system
EP2734112A1 (en) Methods and systems for determining physiological parameters using template matching
US8840562B2 (en) Signal processing warping technique
WO2014043258A1 (en) Methods and systems for processing physiological signals
US20110306858A1 (en) Systems And Methods For Wavelet Transform Using Mean-Adjusted Wavelets
CN110248591B (en) Sensor device and method for sensing physiological information of a subject
Ram et al. Use of multi-scale principal component analysis for motion artifact reduction of PPG signals
US20140187884A1 (en) Systems and methods for ensemble averaging in pulse oximetry
US8437822B2 (en) System and method for estimating blood analyte concentration
US8571621B2 (en) Minimax filtering for pulse oximetry
US20100087714A1 (en) Reducing cross-talk in a measurement system

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06815829

Country of ref document: EP

Kind code of ref document: A1